A Look into Fluoroscopy Systems Industry……Deep Analysis…..
The global fluoroscopy
systems/equipment market
size is expected to reach USD 4.74
billion by 2025, according to a new report by Grand View Research, Inc. The
unprecedented growth is believed to be a consequence of rising patient
preference for minimally invasive surgeries. These devices facilitate early
diagnosis and reduce treatment duration in majority of surgical procedures.
With Covid-19 infections rising globally, the
apprehension regarding a shortage of essential life-saving devices and other
essential medical supplies in order to prevent the spread of this pandemic and
provide optimum care to the infected also widens. In addition, till a
pharmacological treatment is developed, ventilators act as a vital treatment
preference for the COVID-19 patients, who may require critical care. Moreover,
there is an urgent need for a rapid acceleration in the manufacturing process
for a wide range of test-kits (antibody tests, self-administered, and others).
The report will account for Covid19 as a key market contributor.
The growing demand is also a
consequence of improved cost-efficiency, safety, efficacy, rapid recovery, and
reduced hospital stay. These factors anticipated to fuel the demand for
fluoroscopy equipment over the forecast period. Other advantages include fewer
incision wounds and postsurgical complications that lead to higher patient
satisfaction.
The market is also driven by technological
advancements such as incorporation of radiation dose monitoring tools for
optimized radiation in fluoroscopy equipment. Other advancements include
robotically controlled C-arms, integrated navigation tools, and image guidance
software. These advancements have led to enhanced image guidance during
interventional, ablation, and biopsy procedures as well as improved
optimization of working procedures.
The
global market is highly competitive in nature. This competition is marked by
implementation of sustainability strategies by the prominent companies such as
GE Healthcare, Philips Healthcare, and Siemens Healthineers, which accounts for
their dominant market share. These companies focus on various strategies such
as geographical expansion, new product development initiatives, and mergers
& acquisitions.
To Request Sample Copy of this report, click the link:
Further Key Findings From the Report
Suggest:
·
C-arms segment is predicted to
witness exponential growth owing to high cost-efficiency and wide applicability
in different fields such as traumatology, orthopedics, vascular surgery for
intraoperative imaging, and others
·
Cardiovascular emerged as the
largest application segment in 2016 as a consequence of high prevalence of
cardiovascular diseases, raising the clinical urgency for adoption of
fluoroscopy equipment
·
Hospitals held the largest
share in end-use segment due to high patient volume, consistent readmissions,
and easy availability of high-end equipment
·
North America accounted for the
largest share, which can be attributed to the extensive R&D activities that
are likely to provide platform for growth through consistent approvals of new
product
·
The fluoroscopy equipment
market in Asia Pacific is projected to witness substantial growth over the next
decade, due to growing awareness pertaining to availability and benefits of
these devices, further triggering significant penetration
·
GE Healthcare, Philips
Healthcare, and Siemens Healthineers together accounted for a dominant share in
the global fluoroscopy equipment market in 2016
·
The key companies are
aggressively undertaking collaborative strategies, new and advanced product
development activities, and mergers & acquisitions leading to significant
growth
·
In May 2015, Philips Healthcare
launched DuoDiagnost, an integrated radiography and fluoroscopy system. This
equipment was launched to yield higher price-performance ratio in different
applications and achieve a greater return on investment
The
global fluoroscopy systems/equipment market size was estimated at 3.05 billion
in 2016 and is expected to grow at a CAGR of 5.1% during the forecast period.
The market is predominantly driven by rising number of interventional radiology
procedures that demand real-time imaging such as that in fluoroscopy.
According
to a research published in NCBI, usage of CT fluoroscopy in interventional
radiology procedures have led to remarkable decrease in procedure time and
radiation dose as well as radiation associated risks in comparison with
conventional CT guidance procedures. The aforementioned benefits are likely to
increase the adoption of these devices over the coming years.
These
equipment is consistently being used in wide range of interventional
radiological procedures, especially in the treatment of conditions such as
varicose veins, Peripheral Artery Disease (PAD), pulmonary embolism, deep vein
thrombosis, abdominal aortic aneurysms, and other prevalent medical conditions.
This consistent usage is anticipated to impel fluoroscopy systems market growth
potential in future.
In
addition, increasing number of orthopedic surgeries & angiography as a
consequence of sport injuries and a growing geriatric population base are
believed to be high impact rendering drivers. Hand-held fluoroscopes are
gaining popularity in emergency facilities and on-site settings due to their
capacity to perform efficient real-time injury assessment in athletes. The
advent of fluoroscopes in sports medicine is also predicted to be a result of
associated benefits, such as high cost-efficiency and portability.
Have any Query? Ask our Experts:
Fluoroscopy
devices held the largest share of over 69.0% in the product segment in 2016.
The dominant share captured by this segment is believed to be a consequence of
usage in wide array of procedures such as image-guided biopsy, angiography, and
discography. In addition, increasing usage of fluoroscopes in previously
unexplored applications such as quality assurance and nondestructive testing of
medical devices is expected to be a key factor contributing toward the
substantial share of this segment.
Associated
benefits with fluoroscopy devices such as high portability, radiation
sensitivity, X-ray recording capability optical magnification, and lower levels
of scattered radiation are responsible for it emerging as the dominant segment.
Furthermore, fluoroscopy devices are relatively less affected by body surfaces,
resulting in greater clarity, stability, and real-time tracking of images.
Grand View Research has segmented the
global fluoroscopy equipment market on the basis of product, application,
end use:
Fluoroscopy Equipment Product Outlook (Revenue, USD
Million, 2014 - 2025)
·
Fluoroscopy Devices
·
C-arms
o Mini C-arms
o Full Size C-arms
Fluoroscopy Equipment Application Outlook (Revenue,
USD Million, 2014 - 2025)
·
Orthopedic
·
Cardiovascular
·
Pain Management & Trauma
·
Neurology
·
Gastrointestinal
·
Urology
·
General Surgery
·
Others
Fluoroscopy Equipment End-use Outlook (Revenue, USD
Million, 2014 - 2025)
·
Hospitals
·
Diagnostic Centers
·
Specialty Clinics
About Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
Comments
Post a Comment